These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27984095)

  • 1. Acute oral 18-methoxycoronaridine (18-MC) decreases both alcohol intake and IV nicotine self-administration in rats.
    Rezvani AH; Cauley MC; Slade S; Wells C; Glick S; Rose JE; Levin ED
    Pharmacol Biochem Behav; 2016; 150-151():153-157. PubMed ID: 27984095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats.
    Rezvani AH; Overstreet DH; Yang Y; Maisonneuve IM; Bandarage UK; Kuehne ME; Glick SD
    Pharmacol Biochem Behav; 1997 Oct; 58(2):615-9. PubMed ID: 9300627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18-MC reduces methamphetamine and nicotine self-administration in rats.
    Glick SD; Maisonneuve IM; Dickinson HA
    Neuroreport; 2000 Jun; 11(9):2013-5. PubMed ID: 10884062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats.
    Glick SD; Maisonneuve IM; Visker KE; Fritz KA; Bandarage UK; Kuehne ME
    Psychopharmacology (Berl); 1998 Oct; 139(3):274-80. PubMed ID: 9784085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel medications for drug addiction. The legacy of an African shrub.
    Glick SD; Maisonneuve IM
    Ann N Y Acad Sci; 2000; 909():88-103. PubMed ID: 10911925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
    Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
    Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of caffeine on alcohol consumption and nicotine self-administration in rats.
    Rezvani AH; Sexton HG; Johnson J; Wells C; Gordon K; Levin ED
    Alcohol Clin Exp Res; 2013 Sep; 37(9):1609-17. PubMed ID: 23895206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration.
    Carnicella S; He DY; Yowell QV; Glick SD; Ron D
    Addict Biol; 2010 Oct; 15(4):424-33. PubMed ID: 21040239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
    Glick SD; Maisonneuve IM; Szumlinski KK
    Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.
    Maisonneuve IM; Glick SD
    Pharmacol Biochem Behav; 2003 Jun; 75(3):607-18. PubMed ID: 12895678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noribogaine reduces nicotine self-administration in rats.
    Chang Q; Hanania T; Mash DC; Maillet EL
    J Psychopharmacol; 2015 Jun; 29(6):704-11. PubMed ID: 25995321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.
    Taraschenko OD; Shulan JM; Maisonneuve IM; Glick SD
    Synapse; 2007 Jul; 61(7):547-60. PubMed ID: 17447255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administration.
    Glick SD; Sell EM; McCallum SE; Maisonneuve IM
    Eur J Pharmacol; 2011 Nov; 669(1-3):71-5. PubMed ID: 21871879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.
    Scuppa G; Cippitelli A; Toll L; Ciccocioppo R; Ubaldi M
    Drug Alcohol Depend; 2015 Nov; 156():126-132. PubMed ID: 26383997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.
    Maisonneuve IM; Glick SD
    Eur J Pharmacol; 1999 Oct; 383(1):15-21. PubMed ID: 10556676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18-Methoxycoronaridine acts in the medial habenula to attenuate behavioral and neurochemical sensitization to nicotine.
    Eggan BL; McCallum SE
    Behav Brain Res; 2016 Jul; 307():186-93. PubMed ID: 27059333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats.
    Rezvani AH; Slade S; Wells C; Yenugonda VM; Liu Y; Brown ML; Xiao Y; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2017 Sep; 234(17):2517-2523. PubMed ID: 28555315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between 18-methoxycoronaridine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization.
    Szumlinski KK; McCafferty CA; Maisonneuve IM; Glick SD
    Brain Res; 2000 Jul; 871(2):245-58. PubMed ID: 10899291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.
    Rho B; Glick SD
    Neuroreport; 1998 May; 9(7):1283-5. PubMed ID: 9631413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased alcohol preference and intake in nicotine-preferring rats.
    Ozturk B; Pogun S; Kanit L
    Am J Drug Alcohol Abuse; 2020 Jul; 46(4):408-420. PubMed ID: 31860364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.